Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 10 (October)

1. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer.
   Lancet Oncol, 7(10): 859-68. [Abstract] [Full-text]
2. Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: A university teaching hospital experience.
   Int J Gynecol Cancer, 16(5): 1766-9. [Abstract] [Full-text]
3. Measurement of vaginal length: Reliability of the vaginal sound--a Gynecologic Oncology Group study.
   Int J Gynecol Cancer, 16(5): 1749-55. [Abstract] [Full-text]
4. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
   Cancer, 107(7): 1634-41. [Abstract] [Full-text]
5. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
   Int J Radiat Oncol Biol Phys, 66(3): 818-24. [Abstract] [Full-text]
6. Barriers to the provision of evidence-based psychosocial care in oncology.
   Psychooncology, 15(10): 863-72. [Abstract] [Full-text]
7. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
   Int J Radiat Oncol Biol Phys, 66(3): 647-53. [Abstract] [Full-text]
8. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
   Depress Anxiety, 23(7): 441-8. [Abstract] [Full-text]
9. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.
   Clin Cancer Res, 12(19): 5693-7. [Abstract] [Full-text]
10. The role of nutrition in oncology: a need for a change of attitude and curriculum.
    J Cancer Educ, 21(2): 89-91. [Abstract] [Full-text]
11. Cancer Research Training: The Southwest Oncology Group Young Investigator Training Program (YITP).
    J Cancer Educ, 21(2): 77-9. [Abstract] [Full-text]
12. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
    Mycoses, 49(6): 457-62. [Abstract] [Full-text]
13. Assessing the total costs of blood delivery to hospital oncology and haematology patients.
    Curr Med Res Opin, 22(10): 1903-9. [Abstract] [Full-text]
14. Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
    Cancer, 107(4): 676-85. [Abstract] [Full-text]
15. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    BMC Cancer, 6: 228. [Abstract] [Full-text]
16. Laparoscopic surgery in gynaecological oncology.
    Eur J Surg Oncol, 32(8): 853-8. [Abstract] [Full-text]
17. Gynaecological oncology perspective on management of the menopause.
    Eur J Surg Oncol, 32(8): 892-7. [Abstract] [Full-text]
18. Ultra-radical compartmentalized surgery in gynaecological oncology.
    Eur J Surg Oncol, 32(8): 859-65. [Abstract] [Full-text]
19. Key clinical trials in gynaecological oncology.
    Eur J Surg Oncol, 32(8): 887-91. [Abstract] [Full-text]
20. Photodynamic therapy in oncology.
    Oncologist, 11(9): 1034-44. [Abstract] [Full-text]
21. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.
    Oncologist, 11(9): 1025-33. [Abstract] [Full-text]
22. Complementary and alternative medicine in pediatric oncology: availability and institutional policies in Canada--a report from the Children's Oncology Group.
    Pediatr Blood Cancer, 47(7): 955-8. [Abstract] [Full-text]
23. Information from the Internet: attitudes of Australian oncology patients.
    Intern Med J, 36(11): 718-23. [Abstract] [Full-text]
24. Discontinued drugs in 2005: oncology drugs.
    Expert Opin Investig Drugs, 15(11): 1309-18. [Abstract] [Full-text]
25. Importance of patient examination to clinical quality assurance in head and neck radiation oncology.
    Head Neck, 28(11): 967-73. [Abstract] [Full-text]
26. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).
    Phys Med Biol, 51(21): 5409-17. [Abstract] [Full-text]
27. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
    Radiother Oncol, 81(1): 9-17. [Abstract] [Full-text]
28. Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology.
    Eur J Med Chem, 41(10): 1144-52. [Abstract] [Full-text]
29. Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand?
    Eur J Cancer, 42(16): 2675-2677. [Abstract] [Full-text]
30. Information seeking during "bad news" oncology interactions: Question asking by patients and their companions.
    Soc Sci Med, 63(11): 2974-85. [Abstract] [Full-text]
31. Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.
    Expert Opin Pharmacother, 7(16): 2309-18. [Abstract] [Full-text]
32. Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology.
    J Neurooncol, 80(2): 211-3. [Abstract] [Full-text]
33. Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
    Clin Cancer Res, 12(20): 6094-9. [Abstract] [Full-text]
34. Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecol Oncol, 103(2): 523-6. [Abstract] [Full-text]
35. Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.
    Gynecol Oncol, 103(2): 446-50. [Abstract] [Full-text]
36. Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
    Gynecol Oncol, 103(2): 473-8. [Abstract] [Full-text]
37. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Gynecol Oncol, 103(2): 391-6. [Abstract] [Full-text]
38. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Cancer, 107(9): 2197-205. [Abstract] [Full-text]
39. Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.
    Ann Oncol, 17(11): 1687-92. [Abstract] [Full-text]
40. Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
    Leuk Lymphoma, 47(10): 2140-6. [Abstract] [Full-text]
41. Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy.
    BMC Oral Health, 6: 13. [Abstract] [Full-text]
42. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
    J Clin Oncol, 24(31): 5091-7. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.